Internal Reference Number: FOI_6402
Date Request Received: 15/12/2021 00:00:00
Date Request Replied To: 04/01/2022 00:00:00
This response was sent via: By Email
Request Summary: Medication Information
Request Category: Companies
| Question Number 1: How many patients have been treated (for any condition) in the last 4 months with: 鈥� Benralizumab 鈥� Omalizumab 鈥� Reslizumab 鈥� Mepolizumab | |
| Answer To Question 1: In the period August to November 2021 we had the following number of patients who have been issued the below drugs. This is a count of patients, not a count of issues. Benralizumab = 0 Omalizumab = 19 Reslizumab = 0 Mepolizumab = 0 | |
| Question Number 2: Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by following age-groups: 鈥� Age 6-11 鈥� Age 12-17 鈥� Age 18 and above | |
| Answer To Question 2: Of the patients from Q1, the breakdown by age group is as follows: Omalizumab Age 6-11 = 0 Omalizumab Age 12-17 = 0 Omalizumab Age 18+ = 19 | |
| Question Number 3: How many patients have been treated in the last four months with Dupilumab for Asthma ONLY? | |
| Answer To Question 3: We aren't able to answer this question as we do not have the information that links drugs issued to the condition they have been issued for. | |
| Question Number 4: How many patients has your trust treated (for any condition) in the last 12 months with the following drugs: 鈥� Genotropin 鈥� Humatrope 鈥� Norditropin 鈥� Nutropin 鈥� Omnitrope 鈥� Saizen 鈥� Zomacton | |
| Answer To Question 4: In the period December 2020 to November 2021 we had the following number of patients who have been issued the below drugs. Small numbers have been removed in line with Information Governance guidelines. Genotropin = <=5 Humatrope = 0 Norditropin = 0 Nutropin = <=5 Omnitrope = <=5 Saizen = 0 Zomacton = 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at 黑料网 District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
